1-20 of 47
Karen Seiter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Time to Response and Overall Survival in Patients with m IDH1 Relapsed/Refractory Acute Myeloid Leukemia Treated with Olutasidenib

Eunice S. Wang, Jorge E. Cortes, Justin M. Watts, Brian A. Jonas, Andrew H Wei, Jay Yang, Joseph G Jurcic, Gail J. Roboz, Karen Seiter, Alice Mims, Karen Yee, Brent Ferrell, Shira N. Dinner, William B. Donnellan, William Blum, Francois Di Trapani, Hua Tian, Stephane De Botton
Journal: Blood
Blood (2024) 144 (Supplement 1): 1514.
https://doi.org/10.1182/blood-2024-198504
Published: 2024
Journal Articles

Daratumumab for Refractory Autoimmune Leukopenia: A Case Report

Xiaoyang Wang, Michael Guo, Karen Seiter, Amir Steinberg, Fauzia Paracha, Christopher R. Reilly, Fouzia Alam Shakil, Delong Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 5388.
https://doi.org/10.1182/blood-2023-181141
Published: 2023
Journal Articles

Equity and Resource Allocation: The Case for Allogeneic Transplant in Emergency Medicaid Patients

Kevin Hernandez, Tauseef Ahmed, Delong Liu, Karen Seiter, Amir Steinberg
Journal: Blood
Blood (2023) 142 (Supplement 1): 7349.
https://doi.org/10.1182/blood-2023-178225
Published: 2023
Journal Articles

Management of Bone Marrow Transplants in Incarcerated Patients with Plasma Cell Dyscrasias: A Case Series

Yasmeen Mahayni, Tauseef Ahmed, Karen Seiter, Amir Steinberg
Journal: Blood
Blood (2023) 142 (Supplement 1): 7350.
https://doi.org/10.1182/blood-2023-178271
Published: 2023
Journal Articles

Factors Impacting Response to Olutasidenib in Patients with mIDH1 Acute Myeloid Leukemia

Eunice S. Wang, Brian A. Jonas, Justin M. Watts, Joseph Jurcic, P. Brent Ferrell, Jr., Shira N. Dinner, Jay Yang, Karen Seiter, Alice Mims, William B. Donnellan, William Blum, Jorge Cortes
Journal: Blood
Blood (2023) 142 (Supplement 1): 6047.
https://doi.org/10.1182/blood-2023-187584
Published: 2023
Journal Articles

Calr+ Myelofibrosis/BCR-ABL Chronic Myeloid Leukemia Overlap Syndrome Treated with Asciminib

Talia M Saal, Christine Pellegrino, Tauseef Ahmed, Karen Seiter, Delong Liu, Amir Steinberg
Journal: Blood
Blood (2023) 142 (Supplement 1): 6423.
https://doi.org/10.1182/blood-2023-184820
Published: 2023
Journal Articles

Treatment Patterns and Outcomes of Patients with Acute Myeloid Leukemia (AML) from 2013 to 2022: A Connect ® Myeloid Registry Study

David L. Grinblatt, Gail J. Roboz, Daniel A. Pollyea, Mikkael A. Sekeres, Bart L. Scott, Karen Seiter, Amer M. Zeidan, Jay L. Patel, Guillermo Garcia-Manero, Rami S. Komrokji, Michael R. Savona, Irene S. Degutis, Pavel Kiselev, Edward Yu, Willem Heydendael, Ying Qiu, Sara Vergara, Ali McBride, Harry P. Erba
Journal: Blood
Blood (2023) 142 (Supplement 1): 593.
https://doi.org/10.1182/blood-2023-189963
Published: 2023
Journal Articles

CLAG-Based Chemotherapy in Previously Untreated AML Patients: 12 Year Follow-up

Rohan Kapur, Alec M Weber, Juan Trias, Keshav Raghavendran, Stephanie Germani-Danyko, Miles Jackson, Amir Steinberg, Delong Liu, Karen Seiter
Journal: Blood
Blood (2023) 142 (Supplement 1): 5913.
https://doi.org/10.1182/blood-2023-179903
Published: 2023
Journal Articles

Treatment Patterns and Outcomes of Patients with Primary or Secondary Acute Myeloid Leukemia By Type of Site (Academic or Community/Government): A CONNECT® Myeloid Registry Study

Bart L. Scott, Michael R. Savona, Gail J. Roboz, Karen Seiter, Daniel A. Pollyea, Irene S. DeGutis, Pavel Kiselev, Edward Yu, Ali McBride, Willem Heydendael, Harry P. Erba
Journal: Blood
Blood (2022) 140 (Supplement 1): 8923–8925.
https://doi.org/10.1182/blood-2022-158068
Published: 2022
Journal Articles

Treatment Patterns and Outcomes of Patients with NPM1 + Acute Myeloid Leukemia (AML) Enrolled in the CONNECT® Myeloid Disease Registry

Daniel A. Pollyea, Jaroslaw P. Maciejewski, Gail J. Roboz, Karen Seiter, Bart L. Scott, Irene S. DeGutis, Pavel Kiselev, Edward Yu, Ali McBride, Willem Heydendael, Harry P. Erba
Journal: Blood
Blood (2022) 140 (Supplement 1): 11844–11846.
https://doi.org/10.1182/blood-2022-156679
Published: 2022
Journal Articles

A Retrospective Pilot Study: Outcomes of R-Hypercvad in Aggressive Large B-Cell Lymphoma

Rohan Kapur, Juliet Meir, Tauseef Ahmed, Delong Liu, Karen Seiter, Richard Sweeney, Amir Steinberg
Journal: Blood
Blood (2022) 140 (Supplement 1): 12092–12093.
https://doi.org/10.1182/blood-2022-160449
Published: 2022
Journal Articles

First Reported Case Series of Combined Treatment with CLAG and Venetoclax for Acute Myeloid Leukemia (AML)

Esewi Aifuwa, Tauseef Ahmed, Delong Liu, Karen Seiter, Amir Steinberg
Journal: Blood
Blood (2022) 140 (Supplement 1): 11732–11733.
https://doi.org/10.1182/blood-2022-167279
Published: 2022
Journal Articles

Patterns of Family History of Cancer in Adults with Hematologic Malignancies

Karen Seiter, Kyaw Swa, Kyaw Htun, Paul Baskind, Delong Liu
Journal: Blood
Blood (2021) 138 (Supplement 1): 4378.
https://doi.org/10.1182/blood-2021-147900
Published: 2021
Journal Articles

Treatment Patterns and Survival Outcomes of Patients with Acute Myeloid Leukemia Who Achieved Remission in the Connect ® Myeloid Disease Registry

Gail J. Roboz, Mehrdad Abedi, Michael A. Thompson, Mikkael A. Sekeres, Daniel A. Pollyea, Karen Seiter, Edward Yu, Pavel Kiselev, Michelle Little, Irina Fernandez, Irene S. DeGutis, Harry P. Erba
Journal: Blood
Blood (2021) 138 (Supplement 1): 279.
https://doi.org/10.1182/blood-2021-145849
Published: 2021
Journal Articles

Olutasidenib (FT-2102), an IDH1m Inhibitor As a Single Agent or in Combination with Azacitidine, Induces Deep Clinical Responses with Mutation Clearance in Patients with Acute Myeloid Leukemia Treated in a Phase 1 Dose Escalation and Expansion Study

Justin M. Watts, MD, Maria R. Baer, MD, Jay Yang, MD, Thomas Prebet, MD PhD, Sangmin Lee, MD, Gary J. Schiller, MD, Shira Dinner, MD, Arnaud Pigneux, Pau Montesinos, MD PhD, Eunice S. Wang, MD, Karen Seiter, MD, Andrew H. Wei, PhD FRACP, FRCPA, MBBS, Stephane De Botton, Montserrat Arnan Sangerman, William B. Donnellan, MD, Brian A Jonas, MD PhD, Paul Brent Ferrell, Jr., MD, Kim-Hien Dao, DO, PhD, Patrick Kelly, MD, Jennifer Sweeney, Sanjeev Forsyth, Sylvie Guichard, Julie Brevard, Patrick Henrick, Hesham Mohamed, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 231.
https://doi.org/10.1182/blood-2019-123920
Published: 2019
Journal Articles

Phase 1 Study of the IDH1m Inhibitor FT-2102 As a Single Agent in Patients with IDH1 m Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Justin Watts, MD, Maria R. Baer, MD, Jay Yang, MD, Shira Dinner, MD, Sangmin Lee, MD, Karen Seiter, MD, Thomas Prebet, MD PhD, Gary J. Schiller, MD, Paul Brent Ferrell, Jr., MD, Kim-Hien Dao, DO, PhD, Hagop M. Kantarjian, MD, Patrick Kelly, MD, Ping Li, PhD, Jennifer Sweeney, Courtney Watson, Hesham Mohamed, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1453.
https://doi.org/10.1182/blood-2018-99-114263
Published: 2018
Journal Articles

Comparison of Healthcare Resource Utilization and Costs Related to Infections between Patients Newly Diagnosed with Chronic Myeloid Leukemia Treated with Dasatinib and Nilotinib As First-Line Therapy in the United States

Karen Seiter, MD, Dominick Latremouille-Viau, Annie Guerin, MS, Briana Ndife, MPH, Karen Habucky, PhD, George J Joseph, BPharm, MS, PhD, Irina Pivneva, PhD, Patrick Gagnon-Sanschagrin, MS, Derek H Tang, BSPharm, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3391.
https://doi.org/10.1182/blood.V130.Suppl_1.3391.3391
Published: 2017
Journal Articles

Results of a Phase 3 Study of Elderly Patients with Newly Diagnosed AML Treated with Sapacitabine and Decitabine Administered in Alternating Cycles

Hagop M. Kantarjian, MD, Kebede H. Begna, MD, Jessica K. Altman, MD, Stuart L. Goldberg, MD, Mikkael A. Sekeres, MD MS, Stephen A Strickland, Stephen E. Rubenstein, MD, Martha L. Arellano, MD, David F. Claxton, Maria R. Baer, MD, Marc Gautier, MD, Ellin Berman, MD, Karen Seiter, MD, Scott R Solomon, MD, Gary J. Schiller, MD, Selina Luger, MD FRCPC, Aleksandra Butrym, Gianluca Gaidano, MD PhD, Xavier Thomas, MD, Pau Montesinos, MD PhD, David A. Rizzieri, MD, Donald P. Quick, MD, Edward Agura, MD, Parameswaran Venugopal, MD, Janakiraman Subramanian, MD, Lori J. Maness, MD, Daniel-Eric Robert, MD, Yosr Hicheri, Tapan Kadia, MD, Farhad Ravandi, MBBS, Marc E. Buyse, ScD, Judy Chiao, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 891.
https://doi.org/10.1182/blood.V130.Suppl_1.891.891
Published: 2017
Journal Articles

Minimal Residual Disease (MRD) Assessment By Multiparametric Flow Cytometry Is Prognostic for Progression-Free Survival in Phase 1/1b Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients Treated with Idasanutlin MDM2 Antagonist

Benjamin Lanza, Giovanni Martinelli, Karen W.L. Yee, MD, Lori Jukofsky, Bernhard Reis, PhD, Steven Blotner, PhD, Mark W. Drummond, PhDMD, Norbert Vey, MD PhD, Karen Seiter, MD, Michael J. Dickinson, MBBS, FRACP, FRCPA, Kevin R. Kelly, MD PhD, Margaret Kasner, MD, Michel Theron, PhD, Jeffrey M. Venstrom, Steven Middleton, PhD, Lin-Chi Chen, MD PhD, Nelson Kinnersley, Gwen Nichols, MD, William E. Pierceall, PhD
Journal: Blood
Blood (2016) 128 (22): 2843.
https://doi.org/10.1182/blood.V128.22.2843.2843
Published: 2016
Journal Articles

CLAG-Based Induction Therapy in Previously Untreated High Risk AML Patients

Karen Seiter, MD, Stephanie Germani, FNP, Julie Martin, FNP, Rosemarie Raffa, FNP, Michele Reilly, ANP, Nasir Ahmed, MD, Paul Baskind, Delong Liu, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4892.
https://doi.org/10.1182/blood.V126.23.4892.4892
Published: 2015